Vertex Pharmaceuticals (VRTX) Income from Discontinued Operations (2013 - 2014)
Vertex Pharmaceuticals (VRTX) posted Income from Discontinued Operations of -$209000.0 for Q4 2014, down 226.56% on a QoQ basis from -$64000.0 in Q3 2014, and up 99.87% year-over-year from -$104566.8 in Q4 2013.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Income from Discontinued Operations (2013 - 2014) Analysis & Trends
Vertex Pharmaceuticals has reported Income from Discontinued Operations for 2 years, with the latest figure at -$209000.0 in Q4 2014.
- On a quarterly basis, Income from Discontinued Operations rose 99.87% year-over-year to -$209000.0 in Q4 2014; TTM through Sep 2015 was -$209000.0, a 99.87% increase from a year earlier, with the FY2014 full-year figure at -$912000.0, up 99.5% from the prior year.
- Income from Discontinued Operations was -$209000.0 for Q4 2014 at Vertex Pharmaceuticals, down from -$64000.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was -$64000.0 in Q3 2014, with the low at -$163.6 million in Q4 2013.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | - |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 8.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2014 | -209,000.00 |
| Sep 30, 2014 | -64,000.00 |
| Jun 30, 2014 | -293,000.00 |
| Mar 31, 2014 | -346,000.00 |
| Dec 31, 2013 | -163.63 Mn |
| Sep 30, 2013 | -7.21 Mn |
| Jun 30, 2013 | -7.36 Mn |
| Mar 31, 2013 | -5.73 Mn |
API Access
Vertex Pharmaceuticals Income from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-discontinued-operations", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();